| PMICX | PMIRX | PMICX / PMIRX | |
| Total Expense Ratio | 1.60 | 1.09 | 147% |
| Annual Report Gross Expense Ratio | 1.82 | 1.31 | 139% |
| Fund Existence | 4 years | 4 years | - |
| Gain YTD | 3.708 | 4.049 | 92% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 924M | 924M | 100% |
| Annual Yield % from dividends | 2.68 | 3.17 | 85% |
| Returns for 1 year | 6.08 | 6.51 | 93% |
| Returns for 3 years | 31.23 | 33.19 | 94% |
| Returns for 5 years | N/A | N/A | - |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BBHLX | 22.87 | 0.19 | +0.84% |
| BBH Partner Fund - International Eq I | |||
| HBLRX | 14.98 | N/A | N/A |
| Hartford Balanced Income R3 | |||
| IAXTX | 5.17 | N/A | N/A |
| VY® T. Rowe Price Divers Mid Cap Gr S2 | |||
| MVGKX | 18.42 | N/A | N/A |
| MFS Low Volatility Global Equity R2 | |||
| LYFAX | 18.53 | N/A | N/A |
| AlphaCentric Life Sciences & Hlthcare A | |||